28215937Raal FJ, Hovingh GK, Blom D, Santos RD, Harada-Shiba M, Bruckert E, Couture P, Soran H, Watts GF, Kurtz C, Honarpour N, Tang L, Kasichayanula S, Wasserman SM, Stein EAThe lancet. Diabetes & endocrinologyAntibodies, Monoclonal; Anticholesteremic Agents; Blood Component Removal; Hyperlipoproteinemia Type IIAdult; Antibodies, Monoclonal, Humanized; Cholesterol, LDL; Drug Therapy, Combination; Female; Homozygote; Humans; Male; PCSK9 Inhibitors; Treatment OutcomeLong-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study. Lancet Diabetes Endocrinol. 2017 04; 5(4):280-290.Lancet Diabetes Endocrinol2017-02-16T00:00:002017Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study.prns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAuthorshipvivo:hasSubjectAreahas subject areaInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedInformationResourcelinked information resourcerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptD001781Procedures16240.980342Blood Component RemovalD000328Living Beings1578255770.254432AdultD000911Chemicals & Drugs33713760.622749Antibodies, MonoclonalD006720Living Beings952000.950709HomozygoteD004359Procedures2748930.819188Drug Therapy, CombinationAuthorship 1166100.3054440.3054441authors10.2513has subject areaD006938Disorders9180.979205Hyperlipoproteinemia Type IID005260Physiology1992444050.191167FemaleD006801Living Beings2262862810.130052HumansD008078Chemicals & Drugs502220.890086Cholesterol, LDLD008297Physiology1931408600.201617MaleD016896Concepts & Ideas101179490.402389Treatment OutcomeD061067Chemicals & Drugs2139290.656166Antibodies, Monoclonal, HumanizedD000924Chemicals & Drugs221370.887985Anticholesteremic Agents